Abstract
Aerosol drug administration using helium-oxygen mixtures as a carrier gas has been advocated in the treatment of severe airway obstruction. Heliums low density has been shown to reduce resistance of gas flow through restricted airways passages, work of breathing, and minute ventilation requirements. Thus, it improves aerosol delivery in patients with acute airway obstruction, during both spontaneous breathing and mechanical ventilation. Although heliox has been shown to improve deposition of particles into the lung, the clinical evidence supporting the benefit of heliox is mixed. This review of the literature from 1934 – 2009 includes a brief review of the history of use of heliox in respiratory medicine, its physical properties and how they relate to the potential effects, limitations, and practical considerations associated with heliox-driven aerosol drug administration in acute and critically ill patients.
Keywords: Helium, oxygen, heliox, inhaled medications, aerosols, bronchodilators, nebulizer
Current Respiratory Medicine Reviews
Title: Aerosol Drug Administration with Helium-Oxygen (Heliox) Mixtures: An Overview
Volume: 6 Issue: 2
Author(s): Arzu Ari and James B. Fink
Affiliation:
Keywords: Helium, oxygen, heliox, inhaled medications, aerosols, bronchodilators, nebulizer
Abstract: Aerosol drug administration using helium-oxygen mixtures as a carrier gas has been advocated in the treatment of severe airway obstruction. Heliums low density has been shown to reduce resistance of gas flow through restricted airways passages, work of breathing, and minute ventilation requirements. Thus, it improves aerosol delivery in patients with acute airway obstruction, during both spontaneous breathing and mechanical ventilation. Although heliox has been shown to improve deposition of particles into the lung, the clinical evidence supporting the benefit of heliox is mixed. This review of the literature from 1934 – 2009 includes a brief review of the history of use of heliox in respiratory medicine, its physical properties and how they relate to the potential effects, limitations, and practical considerations associated with heliox-driven aerosol drug administration in acute and critically ill patients.
Export Options
About this article
Cite this article as:
Ari Arzu and B. Fink James, Aerosol Drug Administration with Helium-Oxygen (Heliox) Mixtures: An Overview, Current Respiratory Medicine Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339810791171278
DOI https://dx.doi.org/10.2174/157339810791171278 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
When Does Food Refusal Require Professional Intervention?
Current Nutrition & Food Science Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease
Current Rheumatology Reviews Pathogenesis-Oriented Targets for Adjunctive Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets The Future of Angiotensin II Inhibition in Cardiovascular Medicine
Current Drug Targets - Cardiovascular & Hematological Disorders Genetically Modified Endothelial Progenitor Cells in the Therapy of Cardiovascular Disease and Pulmonary Hypertension
Current Vascular Pharmacology Glutathione Peroxidase: A Potential Marker for the Most Common Diseases and Disorders
Recent Patents on Biomarkers Paclitaxel Efficacy is Increased by Parthenolide via Nuclear Factor- KappaB Pathways in In Vitro and In Vivo Human Non–Small Cell Lung Cancer Models
Current Cancer Drug Targets Ventilator-Associated Tracheobronchitis
Current Respiratory Medicine Reviews Oxidative Stress in Cardiovascular Disease: A New Avenue Toward Future Therapeutic Approaches
Recent Patents on Cardiovascular Drug Discovery The Impetus of COVID -19 in Multiple Organ Affliction Apart from Respiratory Infection: Pathogenesis, Diagnostic Measures and Current Treatment Strategy
Infectious Disorders - Drug Targets Editorial [Hot Topic:Cell Metabolism as Therapeutic Target in Human Disease (Executive Guest Editors: Walter Malorni and Rosa Vona)]
Current Pharmaceutical Design Diet Effects on Atherosclerosis in Mice
Current Drug Targets The IL-17 Family of Cytokines - Applications in Respiratory Medicine and Allergology
Recent Patents on Inflammation & Allergy Drug Discovery Cardiovascular Effects of Current and Future Anti-Obesity Drugs
Current Vascular Pharmacology Pharmacological Properties of Physical Exercise in The Elderly
Current Pharmaceutical Design Maternal Nicotine Exposure: Long-Term Effect on Lung Integrity in the Offspring
Current Women`s Health Reviews Cardiac Output by Flotrac/VigileoTM Validation Trials: Are there Reliable Conclusions?
Reviews on Recent Clinical Trials “Oxygen Supply” as Modulator of Aging Processes: Hypoxia and Hyperoxia Models for Aging Studies
Current Aging Science Possible Hypoxia Signaling Induced Alteration of Glucose Homeostasis in Rats Exposed to Chronic Intermittent Hypoxia - Role of Antioxidant (Vitamin C) and Ca2+ Channel Blocker (Cilnidipine)
Current Signal Transduction Therapy Immunologic Considerations in Heart Transplantation for Congenital Heart Disease
Current Cardiology Reviews